Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock…
InnoCare Pharma Limited’s $287 Million Initial Public Offering


Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock…
…